Navigation Links
Silicon Valley Technology Leaders LaserCard Corporation and Tesla Motors Sign LaserPass Secure Access Deal
Date:9/3/2007

LaserCard Launches ID Badge Fulfillment Service

MOUNTAIN VIEW, Calif., Aug. 13 /PRNewswire-FirstCall/ -- LaserCard Corporation (Nasdaq: LCRD) and Tesla Motors announce the successful implementation of an optical memory card-based LaserPass Secure Access System for Tesla's corporate headquarters in San Carlos, California.

Under the agreement, Tesla Motors appointed LaserCard as the supplier and prime contractor for the design and installation of the system which will form the model for a corporate-wide standard. Installation of the next phase at Tesla's research and design center, in Rochester Hills, MI, will start in the coming weeks.

A high-value feature of the overall package is a client fulfillment service, newly-launched by LaserCard, which provides Tesla with fully personalized ID badges. The Facilities department at Tesla Motors uses the LaserPass Access Data Capture System to gather information about each employee and the data is automatically sent to LaserCard's print server via a secure communication protocol named LaserLink. Within 24 hours, the fully personalized card, containing printed and digital images of the cardholder plus his or her biometrics, is delivered to Tesla Motors.

The LaserPass Access System imposes a secure perimeter through which all badge holders can only pass after validating their secure optical/proximity cards. This process enables each individual's access rights for that day, which are controlled by the proximity technology embedded into the LaserPass badge.

"Our expertise is in the design and engineering of groundbreaking electric vehicle technology," said Tim Wenzel, VP of Human Resources and Administration, at Tesla Motors. "Thanks to Laser
'/>"/>

SOURCE LaserCard Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss
2. Ophthalmologists implant five patients with artificial silicon retina microchip
3. Researchers get neurons and silicon talking
4. Nano machine switches between biological and silicon worlds
5. Novel technology detects human DNA mutations
6. Novel antiviral technology inhibits RSV infection in mice
7. Breakthrough Microarray-based Technology for the Study of Cancer
8. The BIOS Initiative - open source biotechnology is born
9. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
10. Revolutionary nanotechnology illuminates brain cells at work
11. Study: homemade gene expression technology unreliable

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...heart pumps some 250 million liters of blood throu...ibers of the heart have to be extremely durable. T..., vice chair of the Department of Medicine III at .... H. A. Katus), has discovered a protein that is r...lar unit, the sarcomere. In cooperation with other...
(Date:11/24/2009)...prescribed by traditional healers in Brazil to tre...pain to fever and flu. , Now for the first time, ... to scientifically prove the pain relieving proper...lian mint. , Testing this ancient South American ...Rocha was able to show that when prepared as a ,te...
(Date:11/24/2009)...ein that may help gut bacteria bind to the gastroi...iotic producers to identify strains that are likel...need to interact with cells lining the gut to have...es in the gut they are more likely to stick around...halie Juge from the Institute of Food Research. I...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Got a pain? -- Have a cup of Brazilian mint 2A sticky solution for identifying effective probiotics 2Data Published in The New England Journal of Medicine Support Use of Raxibacumab 28ABthrax 28TM 29 29 for the Treatment of Inhalation Anthrax 12949 1Data Published in The New England Journal of Medicine Support Use of Raxibacumab 28ABthrax 28TM 29 29 for the Treatment of Inhalation Anthrax 12949 2Data Published in The New England Journal of Medicine Support Use of Raxibacumab 28ABthrax 28TM 29 29 for the Treatment of Inhalation Anthrax 12949 3Data Published in The New England Journal of Medicine Support Use of Raxibacumab 28ABthrax 28TM 29 29 for the Treatment of Inhalation Anthrax 12949 4Data Published in The New England Journal of Medicine Support Use of Raxibacumab 28ABthrax 28TM 29 29 for the Treatment of Inhalation Anthrax 12949 5Go Healthy Announces Negotiations With Bottling Facilities 51183 1Go Healthy Announces Negotiations With Bottling Facilities 51183 2Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast 12948 1Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast 12948 2
...ditions to come , Human-induced climate change i...titudes. To assess whether the onset of drier con...wly developed multicentury tree ring records from ...on drought in northwestern Africa. Using a new set...ntica) and Aleppo pines ( Pinus halepensis ), the ...
...ellow. Do you gun the engine and speed through the...their green, or do you slow down and wait your tur...lity, according to new research from Tel Aviv Univ...he Department of Zoology at Tel Aviv University, r...le adopt risk-taking behaviors similar to those of...
...stigating exactly how chemotherapy drugs kill canc...test the effectiveness of safer new agents. , Dr S...y of Manchester,s Faculty of Life Sciences have ta...otic drugs, which are used extensively for breast ...s, which includes the agent taxol, has been used c...
Other Biology News:AGU journal highlights -- August 6, 2008 2AGU journal highlights -- August 6, 2008 3AGU journal highlights -- August 6, 2008 4AGU journal highlights -- August 6, 2008 5AGU journal highlights -- August 6, 2008 6AGU journal highlights -- August 6, 2008 7Humans' response to risk can be unnecessarily dangerous, finds Tel Aviv University study 2How chemo kills tumors: research to reduce side effects 2How chemo kills tumors: research to reduce side effects 3
(Date:11/24/2009)..., CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNews...ed today it is acquiring the assets of Hyland Seed...tario. The addition of Hyland Seeds will further e...the company anticipates the introduction of Smart...de Tolerant Trait Technology in corn in 2012. The ...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November ... (Nasdaq: DCGN ) today announced the approval of a...cy Court for the District of Delaware,(the "Bankru...etition for,relief under Chapter 11 of the United ..., The orders issued by the Bankruptcy Cou...
(Date:11/24/2009)...SEATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.a...opmentAuthority(OPDA)wererecentlyawarded$2millionb...oard(CERB)inaprivate/publicpartnershiptoconstructt...colnCounty,WA. ,, "Thisinvestmentwillsignifican...70greenjobstoLincolnCounty,"saidBlueMarbleEnergyCE...
(Date:11/24/2009)..., DUBLIN, November 24 /PRNewswire-FirstCall...obal specialty biopharmaceutical company, today,an...n Medicines Agency for,velaglucerase alfa, the com...or the treatment of Type 1 Gaucher disease. This i...e alfa that has been submitted, with previous,subm...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...edic Imaging, PARIS and ATLANTA, Oct. 9 Biospace...arance from the Food and Drug Administration,(FDA)...nited States for 2D,imaging use. EOS 2D|3D techno...ging,allowing images to be obtained with a low dos...al imaging, permitting full-body, uninterrupted di...
...echnology company translating the complexity of hu..., today announced that Andrea Matthews,(age 25), m... Mass High,Tech for its "People to Watch Under 30....idual like Andrea as,part of our team," said Dr. K..."She has been a go-getter ever since she started a...
...ey, OAK BROOK, Ill. and CARY, N.C., Oct. 9 The U...ce of academic medical centers and,their affiliate...ent,technology and services for academic and resea...rship to provide organizations participating in,UH...a robust, easy-to-use,procurement engine to stream...
Other Biology Technology:FDA Clears Biospace med's Revolutionary Low Dose Xray Imager 2FDA Clears Biospace med's Revolutionary Low Dose Xray Imager 3FDA Clears Biospace med's Revolutionary Low Dose Xray Imager 4Genstruct's Andrea Matthews Selected for Mass High Tech's 'People to Watch Under 30' 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 3
10% BSA in TBS from Upstate
Rabbit Anti-Aortic Elastin Polyclonal Antibody, Unconjugated from Abcam
Anti-Mouse VEGF-C Antibody, Unconjugated from Raybiotech, Inc.
Rabbit Anti-MEF2A, phospho (Thr312) Antibody, Unconjugated from Spring Bioscience
Biology Products: